TBPL2 and alkaline phosphatase measurement: The mechanism by which it exerts its effects involves tRF3-Thr-AGT targeting the 3′ UTR of the Z-DNA-binding protein, a key regulator of inflammasome activation, leading to the degradation of ZBP1, which can activate the NLRP3 inflammasome, thereby alleviating AP and controlling disease progression.